斯蒂瓦那托集团将与Duoject医疗系统和IQVIA联合举办网络研讨会,内容包括:
错过了现场讲解?现在就享受网络研讨会的重播吧!
预计到2025年,全球自动注射器市场将大幅增长。市场增长主要是由靶向治疗的日益普及、过敏反应发病率的不断上升、自我管理的转变以及技术进步所推动。生物制品专利到期也有望为市场参与者提供增长机会。
本次网络研讨会将涉及 推动自动注射器领域增长的因素, 探讨挑战、机遇,以及为更安全、更高效、对用户友好的紧急自动注射器平台而不断发展的技术。
Drug Delivery Systems Product Manager, Stevanato Group
Adam Stops is Drug Delivery Systems Product Manager at Stevanato Group, managing auto-injectors, pre-filled variable, fixed-dose pen injectors, large-volume wearable injectors, and inhalers.
Boasting a Ph.D. in Mechanical Engineering and an MBA in business management, Adam Stops has a broad experience in the design, development, and product management of devices and parenteral products.
He has worked with innovative multinational companies leading teams of experts in device research, design, and industrialization throughout his career.
Consultant, Thought Leadership, IQVIA
Yasemin is a Consultant in the European Thought Leadership team based in IQVIA’s London office. Her primary areas of focus are; trends in innovative launches as well as the oncology market, with emphasis on clinical and commercial trends.
Yasemin holds a Masters in Cancer Research and a Bachelor of Science degree in Biomedical Sciences, both from Newcastle University.
Prior to her role in Thought Leadership, Yasemin was part of the Real-World Insights – Global Oncology team, where she worked on the co-ordination and set-up of reports focusing on various cancers.
Vice President Engineering, Duoject Medical Systems